Last update 25 Oct 2025

Fangtuo Biotechnology (Suzhou) Co., Ltd.

Private Company | Subsidiary Company|2020|Shanghai Shi, China|
cn.fronteratherapeutics.com

Overview

Tags

Cardiovascular Diseases
Hemic and Lymphatic Diseases
Other Diseases
AAV based gene therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
AAV based gene therapy2
Top 5 TargetCount
factor IX(Coagulation factor IX)1

Related

2
Drugs associated with Fangtuo Biotechnology (Suzhou) Co., Ltd.
FT-003
Target-
Mechanism
Gene transference
Active Org.
Frontera Therapeutics, Inc.Frontera Therapeutics, Inc.
 [+1]
Originator Org.
Frontera Therapeutics, Inc.Frontera Therapeutics, Inc.
Active Indication
Diabetic macular oedema [+3]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
FT-004
Target
factor IX
Mechanism
factor IX stimulants [+1]
Active Org.
Fangtuo Biotechnology (Suzhou) Co., Ltd. [+1]
Originator Org.
Frontera Therapeutics, Inc.Frontera Therapeutics, Inc.
Active Indication
Hemophilia B
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Fangtuo Biotechnology (Suzhou) Co., Ltd.
CTR20232648
/ Not yet recruitingPhase 1/2
一项多中心、开放、剂量递增和剂量扩展的I/II期临床研究，评估单次静脉输注FT-004对血友病B受试者（内源性FIX活性≤2%）的安全性和有效性
[Translation] A multicenter, open-label, dose-escalation and dose-expansion Phase I/II clinical study evaluating the safety and efficacy of a single intravenous infusion of FT-004 in subjects with hemophilia B (endogenous FIX activity ≤ 2%)
100 Clinical Results associated with Fangtuo Biotechnology (Suzhou) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Fangtuo Biotechnology (Suzhou) Co., Ltd.
Login to view more data
100 Deals associated with Fangtuo Biotechnology (Suzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Fangtuo Biotechnology (Suzhou) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 29 Oct 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
FT-004
 ( factor IX )		Hemophilia B
More
Phase 1/2
FT-003
Diabetic Retinopathy
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free